Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer
Objective: Cisplatin is the main chemotherapy drug for advanced ovarian cancer, but drug resistance often occurs. The aim of this study is to explore the molecular mechanism by which Guizhi Fuling capsule inhibits cisplatin resistance in ovarian cancer. Methods: First, differences in cisplatin resis...
Saved in:
| Main Authors: | Lei Dou, Yan Yan, Enting Lu, Fangmei Li, Dongli Tian, Lei Deng, Xue Zhang, Rongjin Zhang, Yin Li, Yi Zhang, Ye Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332400370X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
by: Disha Mittal, et al.
Published: (2025-08-01) -
Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01) -
Cytotoxicity of natural and synthetic cannabinoids and their synergistic antiproliferative effects with cisplatin in human ovarian cancer cells
by: Ying Chen, et al.
Published: (2024-11-01) -
Intraperitoneal CHEMOPERFUSION TREATMENT OF ADVANCED OVARIAN CANCER WITH DIOXADET COMPARED TO CISPLATIN in experimental s
by: V. G. Bespalov, et al.
Published: (2016-02-01) -
KLF4 promotes cisplatin resistance by activating mTORC1 signaling in ovarian cancer
by: Wanzhen Zhou, et al.
Published: (2024-11-01)